toluene-4-sulfonic acid 4-[2-(2-hydroxy-ethoxy)-ethoxy]-9,10-dioxo-9,10-dihydro-anthracen-1-yl ester

ID: ALA2442834

PubChem CID: 72546228

Max Phase: Preclinical

Molecular Formula: C25H22O8S

Molecular Weight: 482.51

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)Oc2ccc(OCCOCCO)c3c2C(=O)c2ccccc2C3=O)cc1

Standard InChI:  InChI=1S/C25H22O8S/c1-16-6-8-17(9-7-16)34(29,30)33-21-11-10-20(32-15-14-31-13-12-26)22-23(21)25(28)19-5-3-2-4-18(19)24(22)27/h2-11,26H,12-15H2,1H3

Standard InChI Key:  KYLBPQMBXZPHIZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    4.9862  -11.1424    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3925  -10.4257    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5687  -10.4322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7059  -12.8117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7048  -13.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4186  -14.0502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4168  -12.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1312  -12.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1346  -13.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8529  -14.0507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460  -12.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5689  -12.8021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5717  -13.6338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2922  -14.0453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0103  -13.6263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0034  -12.7915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2824  -12.3838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8554  -14.8746    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8415  -11.5629    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2759  -11.5599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7029  -11.5488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7042  -12.3717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4201  -12.7780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1314  -12.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1222  -11.5324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4058  -11.1298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8486  -12.7658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2960  -14.8692    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0114  -15.2778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7229  -14.8626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4384  -15.2712    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1499  -14.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8653  -15.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5769  -14.8495    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  1  3  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 18  2  0
 11 19  2  0
 17 20  1  0
 20  1  1  0
  1 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 14 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Associated Targets(Human)

OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 482.51Molecular Weight (Monoisotopic): 482.1035AlogP: 2.93#Rotatable Bonds: 9
Polar Surface Area: 116.20Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.75CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.29Np Likeness Score: -0.29

References

1. Sangthong S, Ha H, Teerawattananon T, Ngamrojanavanich N, Neamati N, Muangsin N..  (2013)  Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives.,  23  (22): [PMID:24095089] [10.1016/j.bmcl.2013.09.004]

Source